Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model





) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.2%. By the end of trading, WellPoint rose 65 cents (1.1%) to $62.23 on light volume. Throughout the day, 2.1 million shares of WellPoint exchanged hands as compared to its average daily volume of 3.3 million shares. The stock ranged in a price between $62.04-$62.70 after having opened the day at $62.13 as compared to the previous trading day's close of $61.58. Other companies within the Health Services industry that increased today were:




), up 7.4%,

Hill-Rom Holdings



), up 6.2%,

Dehaier Medical Systems



), up 5.1%, and

Edap TMS



), up 5%.

  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

WellPoint, Inc., through its subsidiaries, operates as a health benefits company in the United States. The company offers various network-based managed care plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $20.12 billion and is part of the health care sector. The company has a P/E ratio of 8.4, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 6.6% year to date as of the close of trading on Wednesday. Currently there are nine analysts that rate WellPoint a buy, no analysts rate it a sell, and nine rate it a hold.

TheStreet Ratings rates WellPoint as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front,




), down 14.1%,

Thermogenesis Corporation



), down 11.1%,




), down 7.3%, and

Sunshine Heart



), down 6%, were all laggards within the health services industry with

Align Technology



) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care




FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!

Free download now